Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DexCom, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
DXCM
Nasdaq
3840
www.dexcom.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DexCom, Inc.
DexCom Stelo AI Upgrade Aims To Deepen Consumer Metabolic Health Engagement
- Feb 12th, 2026 1:09 am
Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM
- Feb 11th, 2026 9:00 am
What Are Wall Street Analysts' Target Price for DexCom Stock?
- Feb 11th, 2026 7:31 am
Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow
- Feb 10th, 2026 8:12 pm
Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth?
- Feb 10th, 2026 9:22 am
Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics
- Feb 10th, 2026 7:15 am
1 High-Flying Stock with Impressive Fundamentals and 2 We Ignore
- Feb 8th, 2026 9:32 pm
DexCom’s AI Powered Stelo Pushes Deeper Into Consumer Metabolic Health
- Feb 6th, 2026 3:06 pm
Wearables’ future in healthcare likely to hinge on actionable insights
- Feb 6th, 2026 5:42 am
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
- Feb 5th, 2026 9:39 pm
DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features
- Feb 5th, 2026 10:33 am
DexCom (DXCM) Reports Next Week: Wall Street Expects Earnings Growth
- Feb 5th, 2026 8:00 am
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
- Feb 5th, 2026 5:00 am
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
- Feb 4th, 2026 6:30 am
DexCom’s Q4 Beat And 2026 Targets Tested By Rising CGM Competition
- Jan 31st, 2026 11:07 pm
What DexCom (DXCM)'s Strong Q4 Beat and 2026 Margin Guidance Means For Shareholders
- Jan 31st, 2026 7:09 pm
Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive
- Jan 30th, 2026 12:31 pm
Senseonics wins CE mark for one-year CGM
- Jan 30th, 2026 3:00 am
3 Profitable Stocks for Long-Term Investors
- Jan 28th, 2026 9:34 pm
3 Former Stock Picks Are Quietly Flashing Buy Signals Again
- Jan 28th, 2026 9:33 pm
Scroll